Product Switch Grant
After approval by GAVI for a specific type of vaccine support, a country may later wish to switch to a different presentation of the vaccine with the same antigen, e.g. from lyophilised pentavalent to liquid pentavalent, or from a one-dose to 10-dose vial format. To facilitate the transition to a different presentation, and if certain criteria are met, countries can apply for an additional grant to help cover the costs associated with the product switch.
- Project ID
47122-18-LBR-25A-Y- Activity status
- 2 - Implementation
- Aid type
- B02 - Core contributions to multilateral institutions
- % to Liberia
- 100.00
Organisations
- Funding
- The Global Alliance for Vaccination and Immunisation
- Extending
- World Health Organisation - core voluntary contributions account (for technical assitance)
- Accountable
- Federal States & Local Governments
- Implementing
- Federal States & Local Governments
Disbursements by fiscal year, quarter
| Fiscal year |
Fiscal quarter |
Value (USD) |
Liberia Value (USD) |
| 2018 |
Q1 |
46,007.00 |
46,007.00 |
Commitments by fiscal year, quarter
| Fiscal year |
Fiscal quarter |
Value (USD) |
Liberia Value (USD) |
| 2017 |
Q3 |
46,007.00 |
46,007.00 |
MTEF projections by fiscal year
| Fiscal year |
Value (USD) |
Liberia Value (USD) |
| 2018 |
23,003.50 |
23,003.50 |
| 2017 |
23,003.50 |
23,003.50 |
| CRS code |
% |
|
Basic health care
(12220)
|
100.0
|